C-RAD AB Revenue and Competitors
Employee Data
- C-RAD AB has 92 Employees.
- C-RAD AB grew their employee count by 10% last year.
C-RAD AB's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & President | Reveal Email/Phone |
2 | Chief Operating Officer and Head Product Management | Reveal Email/Phone |
3 | Sales Director DACH & CEE | Reveal Email/Phone |
4 | Service Manager EIMEA and APAC | Reveal Email/Phone |
5 | Product Manager - SGRT for Photon Treatment | Reveal Email/Phone |
6 | Servicechef EIMEA/APAC | Reveal Email/Phone |
C-RAD AB Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 92 | 10% | N/A | N/A |
#2 | $7.5M | 89 | 0% | N/A | N/A |
#3 | $7.5M | 129 | 23% | N/A | N/A |
#4 | N/A | 38 | 46% | N/A | N/A |
#5 | N/A | 68 | 21% | N/A | N/A |
#6 | $7.5M | 42 | -25% | N/A | N/A |
#7 | N/A | 64 | -10% | N/A | N/A |
What Is C-RAD AB?
Through detailed knowledge about the radiotherapy business and its customer requirements we offer products for positioning, monitoring, tumor localization and radiation therapy. In new advanced radiation therapy techniques, the radiation dose must be delivered to the tumor with extremely high precision and microsecond timing. Our positioning and scanning products assure just that. Our customers are radiation treatment clinics and diagnostics departments in hospitals worldwide. The aim is to contribute to a higher level of quality and efficiency for the customer. In June 2015, C-RAD also completed its acquisition of the Franco-Belgian Cyrpa group, which added their innovative laser solutions for patient positioning and virtual simulation to the C-RAD portfolio.
keywords:N/AN/A
Total Funding
92
Number of Employees
N/A
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 92 | 3% | N/A |
#2 | $15M | 97 | 10% | N/A |
#3 | $19.4M | 114 | -37% | N/A |
#4 | $30.1M | 123 | 5% | N/A |
#5 | $24.7M | 123 | 7% | N/A |